arrow
J

Jonathan Wickel

friedrich schiller university of jena
H指数:21
被引数:1,749

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Reduced Hospital Incidence of Autoimmune Encephalitis During the COVID-19 Pandemic

COVID-19疫情期间自身免疫性脑炎的医院发病率降低

2026-05-010
PRE
Chimeric antigen receptor T cells in treatment-refractory DAGLA antibody-associated encephalitis

嵌合抗原受体T细胞在抗DAGLA抗体相关脑炎治疗难治性病例中的应用

Med
IF11.8
2025-07-230
OAAI
Intravenous immunoglobulin as first-line acute treatment in adults with autoimmune encephalitis caused by antibodies to NMDAR, LGI1 and CASPR2

静脉注射免疫球蛋白作为由抗NMDAR、LGI1和CASPR2抗体引起的成人自身免疫性脑炎的一线急性治疗

2025-03-250
OA
Real-world multicentre cohort study on choices and effectiveness of immunotherapies in NMOSD and MOGAD

关于NMOSD和MOGAD免疫疗法的选择和有效性的真实世界多中心队列研究

2024-12-270
PRE
Frequency, characteristics, and immunological accompaniments of ataxia in anti-NMDAR antibody-associated encephalitis

抗NMDAR抗体相关性脑炎中共济失调的频率,特征和免疫学伴随

2024-12-130
OAAI
Eculizumab Use in Neuromyelitis Optica Spectrum Disorders
2024-11-122
PRE
Targeted rescue of synaptic plasticity improves cognitive decline in sepsis-associated encephalopathy

突触可塑性的靶向抢救可改善脓毒症相关性脑病的认知功能下降

2024-07-011
OAAI
Time to Disability Milestones and Annualized Relapse Rates in NMOSD and MOGAD
2024-01-1322
OAAI
Early Neuroaxonal Damage in Neurologic Disorders Associated With GAD65 Antibodies
2024-01-012
OAAI
Microglia mediate neurocognitive deficits by eliminating C1q-tagged synapses in sepsis-associated encephalopathy
2023-05-2643
OAAI
Real-world data on eculizumab treatment in NMOSD: high efficacy and potential challenges
2023-04-250
PRE